Literature DB >> 19781700

Vaginal misoprostol for second-trimester pregnancy termination after one previous cesarean delivery.

Ahmad H Naguib1, Hassan M Morsi, Tamer F Borg, Salah T Fayed, Hosam M Hemeda.   

Abstract

OBJECTIVE: To determine the safety and efficacy of using misoprostol vaginally for second-trimester abortion in women with a single previous cesarean delivery.
METHOD: This prospective observational study was carried out at a university hospital in Egypt with 50 pregnant women with 1 previous cesarean delivery; a gestation of at least 16 weeks but less than 20 weeks (group 1) or 20 or more weeks (group 2); and a need to terminate the pregnancy. The regimen was 4 doses of 200 microg of misoprostol applied vaginally every 4 hours daily, with a 12-hour nightly rest from misoprostol applications, until contractions appeared but not for more than 72 hours. The primary outcome was the induction-to-abortion interval.
RESULTS: There were no cases of uterine rupture. Abortion within the study protocol occurred in 45 of the 50 women, for a 90% success rate. There was no significant difference in the induction-to-abortion interval between the 2 groups.
CONCLUSION: Inducing abortion with lower misoprostol doses appear to be safe and effective throughout the second trimester in women with a single previous cesarean delivery. Larger randomized trials are needed to validate these results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19781700     DOI: 10.1016/j.ijgo.2009.08.010

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  2 in total

1.  Misoprostol versus High Dose Oxytocin and Laminaria in Termination of Pregnancy in Second Trimester Pregnancies.

Authors:  Azin Alavi; Minoo Rajaei; Malihe Amirian; Lili Nikuee Ghazvini
Journal:  Electron Physician       Date:  2013-11-01

2.  Misoprostol complications in second-trimester termination of pregnancy among women with a history of more than one cesarean section.

Authors:  Marzieh Jamali; Mahmood Bakhtiyari; Fatemeh Arab; Masoumeh Mirzamoradi
Journal:  Obstet Gynecol Sci       Date:  2020-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.